摘要
六维健康状态分类系统(SF-6D)是常用的健康效用测量方法之一。文章系统介绍SF-6D并概述其在国际上最新的研究及应用进展。相较于欧洲五维健康量表,SF-6D在某些疾病领域测量患者效用值时效度更高、结果更可靠。另一方面,可通过转化文献报导的简明健康状况调查问卷(SF-36)的调查结果来估计SF-6D效用值。用此方法估计患者健康效用值将最大化使用现有的SF-36数据,进而极大节省药物经济学研究成本,但此转化模型是否适合国内研究还有待进一步验证。
Cost-utility analysis（CUA） was widely used for health care decision-maker. It systematically introduced ShortForm 61）（SF-6D） and described the latest international research and application progress. Compared with EuroQol 5 Dimensions Question- naire（EQ-51））, SF-6D had higher time validity and more reliable result on estimating patients in some fields. On the other hand, the unity value of SF-6D was estimated based the investigation result of Short Form-36（SF-36） through transferring literature and reports. Based on the method, estimating the health unity of patients＇ health could make the maximized use of the current data of SF-36, so as to save the costs of pharmacoeconomic. However, further research needs to verify that this transfmTnation model is suitable for Chinese.
出处
《中国卫生经济》
北大核心
2018年第2期70-73,共4页
Chinese Health Economics
